| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
| 05/04/2000 | WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 05/04/2000 | WO2000006187A3 Modulation of apoptosis |
| 05/04/2000 | WO2000004868A3 Libraries of polyhydroxamates and their analogs |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | DE19856882C1 New spermatogenesis protein useful for investigation and modulation of spermatogenesis, particularly for diagnosis and treatment of spermatogenesis disorders |
| 05/04/2000 | CA2348833A1 Human phospholipases |
| 05/04/2000 | CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 05/04/2000 | CA2348430A1 Ovary-specific genes and proteins |
| 05/04/2000 | CA2348165A1 Dihydropyridine compounds and methods of use |
| 05/04/2000 | CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | CA2347294A1 Novel g protein coupled receptor protein, dna and its ligand |
| 05/04/2000 | CA2347032A1 O/w emulsion comprising an hydroxylated oil |
| 05/03/2000 | EP0997457A1 3-benzoylindole derivatives and drugs containing the same |
| 05/03/2000 | EP0996635A1 Novel family of pheromone receptors |
| 05/03/2000 | EP0996629A2 Disulfide crosslinked glycoprotein hormone analogs, their preparation and use |
| 05/03/2000 | EP0996457A1 Fsh-releasing peptides |
| 05/03/2000 | EP0996447A1 Combination therapy for modulating the human sexual response |
| 05/03/2000 | EP0754043B1 Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 05/03/2000 | EP0719767B1 Succinamic acid compound, process for producing the same, and use thereof |
| 05/03/2000 | EP0691985B1 Phosphonomethyldipeptides |
| 05/03/2000 | CN1251758A Oral medicinal preparation |
| 05/03/2000 | CN1051929C Bag for dysmenorrhoea and preparation method thereof |
| 05/03/2000 | CN1051924C Emulsive medicine for dam's acyesis and production thereof |
| 05/03/2000 | CN1051921C Methods of inhibiting imperfect tissue repair |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057349 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxphenyl, and aminophenyl alkylsulfonamides and ureas and their use |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6056966 Organic mono- or dinitrate in a pharmaceutically acceptable topical or parenteral carrier |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 05/02/2000 | CA2012170C Novel method of ovulation induction in humans |
| 04/27/2000 | WO2000023473A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | WO2000023460A1 HIGH PURITY COMPOSITION COMPRISING (7α,17α)- 17-HYDROXY- 7-METHYL- 19-NOR-17-PREGN- 5(10)-EN-20-YN-3-ONE |
| 04/27/2000 | WO2000023457A1 Adenine derivatives |
| 04/27/2000 | WO2000023445A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023426A1 Novel imidazoles with anti-inflammatory activity |
| 04/27/2000 | WO2000023425A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023417A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023416A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023415A1 New compounds, their preparation and use |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | WO1999061010A3 Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound |
| 04/27/2000 | CA2347062A1 Multiple domain glycoprotein hormones and methods of using |
| 04/26/2000 | EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995741A1 Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 04/26/2000 | EP0994718A1 Gonadotropin releasing hormone antagonist |
| 04/26/2000 | EP0994708A1 Antagonists of gonadotropin releasing hormone |
| 04/26/2000 | EP0963201A4 Transdermal application of naturally occurring steriod hormones |
| 04/26/2000 | CN1051716C Somatotropin prolonged release |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054457 Benzamide derivatives and their use as vasopressin antagonists |
| 04/25/2000 | US6054308 Arginase II |
| 04/23/2000 | CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000021955A1 Quinazoline derivatives |
| 04/20/2000 | WO2000021951A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 04/20/2000 | WO2000021555A1 Contraception through antagonizing wnt; oocyte maturation with wnt polypeptide |
| 04/20/2000 | WO2000021530A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | WO2000021524A1 Pufa supplements |
| 04/20/2000 | WO2000021511A2 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
| 04/20/2000 | WO2000021508A2 Novel therapeutic use of compounds with beta-3-agonist activity |
| 04/20/2000 | WO2000021503A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/20/2000 | WO1999066913A3 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | WO1999061469A3 Prostate growth-associated membrane proteins |
| 04/20/2000 | WO1999048868A9 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 04/20/2000 | CA2653503A1 The use of ara as a supplement for a lactating woman |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346689A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 04/20/2000 | CA2346464A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | CA2311937A1 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
| 04/19/2000 | EP0994115A2 Process for preparation of pyrazolo-(4,3-d)pyrimidin-7-ones and intermediates thereof |
| 04/19/2000 | EP0994102A1 Cyclic derivatives with a cycloalkylenic chain, process for their preparation and pharmaceutical compositions containing them |
| 04/19/2000 | CN1250771A Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
| 04/19/2000 | CN1250663A 避孕糊剂 Contraception paste |
| 04/18/2000 | US6051712 Piperidine derivatives having renin inhibiting activity |
| 04/18/2000 | US6051603 Novel spermicidal compounds which are organometallic cyclopentadienyl metal complexes, particularly vanadium iv complexes |
| 04/18/2000 | US6051594 Orally administering a formulation of the vasodilator phentolamine to the blood circulation |
| 04/18/2000 | US6051564 Phosphatidic acid-comprising compositions |
| 04/18/2000 | US6051555 Administering a peptide |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/13/2000 | WO2000020423A1 Tricyclic δ3-piperidines as pharmaceuticals |
| 04/13/2000 | WO2000020421A2 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS |
| 04/13/2000 | WO2000020412A1 Quinazolinedione derivatives, preparation and therapeutic uses |
| 04/13/2000 | WO2000020398A1 Biphenylene lactams as prostaglandin receptor ligands |
| 04/13/2000 | WO2000020382A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators |
| 04/13/2000 | WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | WO2000020371A1 Prostaglandin receptor ligands |
| 04/13/2000 | WO2000020358A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 04/13/2000 | WO2000020027A2 Methods for therapeutic vaccination |
| 04/13/2000 | WO2000019990A2 Rar antagonists as male anti-fertility agents |
| 04/13/2000 | WO2000019987A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | WO2000003015A3 Human transport protein homologs |
| 04/13/2000 | WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |